Literature DB >> 30343710

PBC and related extrahepatic diseases.

Annarosa Floreani1, Nora Cazzagon2.   

Abstract

Patients with PBC have at least 60% of probability to have an autoimmune extrahepatic condition. The pathogenesis of these conditions includes a common mechanism involving both innate and adaptive immune responses targeting cholangiocytes and different extrahepatic tissues. The recent EASL guidelines recommend the management of these conditions, although detailed practical treatments have not been indicated. Autoimmune extrahepatic conditions may include: rheumatologic, endocrine, pulmonary, gastrointestinal, dermatologic diseases. This review aims to focus the most important extrahepatic autoimmune conditions associated to PBC with practical recommendation regarding diagnostic approach and management.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CREST disease; Dermatological diseases; Extrahepatic autoimmune conditions; Primary biliary cholangitis; Primary biliary cirrhosis; Pulmonary diseases; Rheumatoid arthritis; Scleroderma; Sjogren's syndrome; Thyroid diseases

Mesh:

Year:  2018        PMID: 30343710     DOI: 10.1016/j.bpg.2018.05.013

Source DB:  PubMed          Journal:  Best Pract Res Clin Gastroenterol        ISSN: 1521-6918            Impact factor:   3.043


  9 in total

Review 1.  [Rheumatism and gastroenterology].

Authors:  Herbert Kellner
Journal:  Orthopade       Date:  2019-11       Impact factor: 1.087

2.  Fluctuations of antimitochondrial antibodies and anti-gp210 antibody in a patient with primary biliary cholangitis and Sjögren syndrome with subsequent autoimmune hemolytic anemia: A case report.

Authors:  Dan-Tong Zhao; Yan-Min Liu; Ying Han; Hai-Ping Zhang; Yan Zhao; Hui-Ping Yan
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.889

3.  Concomitant Sjögren's Syndrome Was Not Associated with a Poorer Response or Outcomes in Ursodeoxycholic Acid-Treated Patients with Primary Biliary Cholangitis.

Authors:  Ping Ni; Ruoting Men; Mengyi Shen; Tingting Wang; Chen Huang; Xiaoli Fan; Li Yang
Journal:  Can J Gastroenterol Hepatol       Date:  2019-06-02

4.  Constitutive Activation of Natural Killer Cells in Primary Biliary Cholangitis.

Authors:  Theresa J Hydes; Matthew D Blunt; Jennifer Naftel; Andres F Vallejo; Grégory Seumois; Alice Wang; Pandurangan Vijayanand; Marta E Polak; Salim I Khakoo
Journal:  Front Immunol       Date:  2019-11-15       Impact factor: 7.561

5.  Anti-mitochondrial Antibodies in Patients with Dilated Cardiomyopathy.

Authors:  Tetsuro Yokokawa; Akiomi Yoshihisa; Tomofumi Misaka; Takamasa Sato; Takashi Kaneshiro; Masayoshi Oikawa; Atsushi Kobayashi; Takayoshi Yamaki; Hiroyuki Kunii; Yasuchika Takeishi
Journal:  Intern Med       Date:  2021-01-15       Impact factor: 1.271

Review 6.  Natural Killer Cells: Potential Biomarkers and Therapeutic Target in Autoimmune Diseases?

Authors:  Elena Gianchecchi; Domenico V Delfino; Alessandra Fierabracci
Journal:  Front Immunol       Date:  2021-02-19       Impact factor: 7.561

Review 7.  Autoimmune liver diseases in systemic rheumatic diseases.

Authors:  Chrong-Reen Wang; Hung-Wen Tsai
Journal:  World J Gastroenterol       Date:  2022-06-21       Impact factor: 5.374

Review 8.  Autoimmune biliary diseases: primary biliary cholangitis and primary sclerosing cholangitis.

Authors:  Samantha Sarcognato; Diana Sacchi; Federica Grillo; Nora Cazzagon; Luca Fabris; Massimiliano Cadamuro; Ivana Cataldo; Claudia Covelli; Alessandra Mangia; Maria Guido
Journal:  Pathologica       Date:  2021-06

9.  Antibodies to the Muscarinic Acetylcholine Receptor M3 in Primary Biliary Cholangitis Inhibit Receptor Function on Cholangiocytes.

Authors:  Christian Mayer; Beate Preuss; Julia Grottenthaler; Christoph Berg; Reinhild Klein
Journal:  Front Immunol       Date:  2020-06-30       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.